Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 1
1989 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for per stenbjerg[Author]
Your search for Per Stounbjerg[Author] retrieved no results
Diabetes-like alterations in hemostatic parameters after growth hormone administration for one week in normal man.
Ingerslev J, Christensen PD, Stenbjerg S, Møller N, Orskov H, Christiansen JS. Ingerslev J, et al. Among authors: stenbjerg s. J Diabet Complications. 1989 Apr-Jun;3(2):103-6. doi: 10.1016/0891-6632(89)90020-2. J Diabet Complications. 1989. PMID: 2526135
The authors studied capillary resistance, factor VIII coagulant antigen (F VIII:Ag), von Willebrand factor (vWf:Ag), fibronectin, fibrinogen, and tissue-type plasminogen activator (t-PA) before, during, and after 1 week's subcutaneous GH administration (6 IU per day divide …
The authors studied capillary resistance, factor VIII coagulant antigen (F VIII:Ag), von Willebrand factor (vWf:Ag), fibronectin, fibrinogen …
Factor VIII inhibitor treatment with high doses of F VIII.
Stenbjerg S, Ingerslev J, Zachariae E. Stenbjerg S, et al. Thromb Res. 1984 Jun 15;34(6):533-9. doi: 10.1016/0049-3848(84)90257-3. Thromb Res. 1984. PMID: 6429891
A hemophilic patient with F VIII inhibitor was treated with intermittent F VIII infusions of 40 - 50 units per kg bodyweight per week. Although the inhibitor declined during treatment, an anamnestic response was recorded on two occasions. A continuous high dose F VI …
A hemophilic patient with F VIII inhibitor was treated with intermittent F VIII infusions of 40 - 50 units per kg bodyweight per …
Continuous high-dose factor VIII for the induction of immune tolerance in haemophilia A patients with high responder state: a description of eleven patients treated.
Scheibel E, Ingerslev J, Dalsgaard-Nielsen J, Stenbjerg S, Knudsen JB. Scheibel E, et al. Among authors: stenbjerg s. Thromb Haemost. 1987 Dec 18;58(4):1049-52. Thromb Haemost. 1987. PMID: 3127918 Clinical Trial.
In six, the inhibitor apparently disappeared (detection limit 0.4 Bethesda Units per ml) (BU/ml), in four patients a low level inhibitor of 0.4-1.4 BU/ml persisted. One patient is still on high-dose schedule. ...
In six, the inhibitor apparently disappeared (detection limit 0.4 Bethesda Units per ml) (BU/ml), in four patients a low level inhibi …